EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity

Chen Chen iD, Siqi Zhang, Ming Sheng, Wei Shao iD

Mediators of Inflammation · 2025-01 · 2025 (1)

DOI: 10.1155/mi/4330574 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mediators of Inflammation, online erschienen am 28.10.2025. Verfasst von Chen Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Hubei University of Chinese Medicine, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Cardiovascular Diseases, Depression. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 346 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression and cardiovascular disease (CVD) frequently coexist, significantly impacting patient prognosis and quality of life. Research indicates that inflammatory responses play a crucial role in the pathogenesis of both conditions. The NLRP3 inflammasome, a key inflammatory signaling platform of the innate immune system, mediates the maturation and release of IL‐1β and IL‐18 and induces pyroptosis, playing a significant role in both depression and CVD. To explore the mechanisms and therapeutic potential of the NLRP3 inflammasome in the comorbidity of depression and CVD, we systematically reviewed recent literature. Our focus was on its activation pathways, expression changes in animal models and clinical samples, and intervention studies. The results indicate that NLRP3 inflammasome is persistently activated in patients with both depression and CVD, and this activation correlates with disease severity. Furthermore, various pharmaceutical drugs and natural compounds have demonstrated synergistic effects by inhibiting the NLRP3 inflammasome pathway. In conclusion, the NLRP3 inflammasome represents a critical molecular mechanism linking depression and CVD, as well as a potential target for combined therapeutic strategies. This area holds significant research and clinical translational value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesCardiovascular DiseasesDepressionHumansAnimalsInterleukin-18Signal TransductionInterleukin-1beta

Stichwörter der Autor:innen

CVDNLRP3 inflammasomedepression

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNLRP3 protein, humanInterleukin-18Interleukin-1beta

Autor:innen und Institutionen

  • First Clinical Medical College, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
  • Department of Neurology, Wuhan No. 1 Hospital/Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, Hubei, China.

ORCID-Profile: Chen Chen, Wei Shao

Zitieren

APA

Chen, C., Zhang, S., Sheng, M., & Shao, W. (2025). NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity. Mediators of Inflammation, 2025(1). https://doi.org/10.1155/mi/4330574

Vancouver

Chen C, Zhang S, Sheng M, Shao W. NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity. Mediators of Inflammation. 2025;2025(1). doi:10.1155/mi/4330574

BibTeX
@article{Chen2025,
  author = {Chen, Chen and Zhang, Siqi and Sheng, Ming and Shao, Wei},
  title = {NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity},
  journal = {Mediators of Inflammation},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/mi/4330574}
}
Kostenlos starten →